Dr. Olivier Clément, PhD, and Dr. Pierre-Henri Lefevre[email protected]Clinical NewsGadolinium chelates for MRI: Where are we now?The safety of MRI contrast agents came under close scrutiny at the Journées Francophones de Radiologie congress. Dr. Olivier Clément, PhD, from Paris and Dr. Pierre-Henri Lefevre from Nîmes provided timely summaries of the current and future status of these products and asked what the literature tells us.October 17, 2016Page 1 of 1Top StoriesNuclear MedicineZurich symposium examines 25 years of PET/CT and its futureTwenty-five years after Zurich’s pioneering PET/CT installation, experts reunited to discuss clinical advances, new tracers, and patient access.MRIRapid-fire research showcases neuroradiology innovationsAIIntegrated diagnostics could cut treatment delaysNuclear MedicineJeremy Calais discusses his move to Paris, European researchSponsor ContentFREE webinar: find your imaging capacity